You are here: Industry Insights > Bharat Biotech

News List

Covaxin booster dose study shows promising results ExpressPharma
January 10, 2022
Bharat Biotech recently announced the results from the highly anticipated trial studying the immunogenicity and safety of the Covaxin vaccine as a booster dose.
Bharat Biotech seeks approval for Phase III intranasal Covid-19 vaccine trial Pharmaceutical-Technology
December 22, 2021
Indian company Bharat Biotech has filed an application with the Drugs Controller General of India (DCGI) seeking approval to commence Phase III clinical trial for its intranasal Covid-19 vaccine BBV154.
Bharat Biotech seeks nod for trial of intranasal vaccine as booster dose expresspharma
December 21, 2021
An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission.
The Lancet publishes Bharat Biotech’s Covaxin phase-III data ExpressPharma
November 15, 2021
Bharat Biotech today announced that the safety and efficacy analysis data from phase-III clinical trials of Covaxin is peer-reviewed and published in The Lancet, the company said in a statement.
Bharat Biotech MD says Ideal time for COVID booster shot is six months after second dose ExpressPharma
November 12, 2021
The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Krishna Ella, Chairman and Managing Director, Bharat Biotech, said yesterday...
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials ExpressPharma
October 29, 2021
Ocugen, Bharat Biotech’s US partner for COVID-19 vaccine Covaxin, yesterday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) to conduct clinical trials.
Centre approves Bharat Biotech’s Ankleshwar plant for Covaxin production: Mandaviya expresspharma
August 12, 2021
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its Ankleshwar-based facility.
Covaxin subjected to over 200 quality control tests, claims Bharat Biotech expresspharma
August 09, 2021
The company released the statement in response to the articles on social media and media outlets regarding the quality of Covaxin.
Facility augmentation of Bharat Biotech and three other PSEs being supported for augmented production of Covaxin: Health Minister expresspharma
August 09, 2021
CDSCO puts in place system to fast track processing of application for clinical trial and approval for COVID-19 vaccines.
Covaxin receives GMP certificate from Hungarian authorities expresspharma
August 06, 2021
Covaxin has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities, Bharat Biotech said in a statement.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page